Acute coronary syndrome: how to reduce the residual inflammatory risk?
Open Access
- 11 March 2020
- journal article
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 25 (2), 113-118
- https://doi.org/10.15829/1560-4071-2020-2-3720
Abstract
Inflammatory mediators play an important role in the pathogenesis of acute coronary syndrome (ACS). The results of experimental and randomized clinical trials on the role of various inflammation inhibitors in the treatment of coronary artery disease (CAD), in particular CANTOS and COLCOT, mark a new stage that can significantly change the clinical course and outcomes of the disease. We analyze our own experience in studying this problem. There are much prospects for the use of immunomodulatory and anti-inflammatory drugs reducing the residual inflammatory risk, but additional studies are needed to determine their role in the treatment of CAD.Keywords
This publication has 23 references indexed in Scilit:
- Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventionsAtherosclerosis, 2018
- CARDIOVASCULAR PREVENTION 2017. NATIONAL GUIDELINESRussian Journal of Cardiology, 2018
- Failure to LaunchJACC: Basic To Translational Science, 2017
- Effect of Darapladib on Major Coronary Events After an Acute Coronary SyndromeJAMA, 2014
- Trends in hospital treatments, including revascularisation, following acute myocardial infarction, 2003–2010: a multilevel and relative survival analysis for the National Institute for Cardiovascular Outcomes Research (NICOR)Heart, 2014
- Stages of atherosclerotic plaque development and unstable plaque types: pathophysiologic and histologic characteristicsRussian Journal of Cardiology, 2013
- Cooling Off Hot Hearts: A Specific Therapy for Vulnerable Plaque?Journal of Invasive Cardiology, 2013
- Association of Mild to Moderate Chronic Kidney Disease With Venous ThromboembolismJournal of the American College of Cardiology, 2012
- Regulation of the Inflammatory Response in Cardiac RepairCirculation Research, 2012
- Comparison of One-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Unprotected Left Main Coronary Artery Disease and Acute Coronary Syndromes (from the CUSTOMIZE Registry)The American Journal of Cardiology, 2011